Bedossa P - Search Results

1

Reversibility of hepatitis C virus-related cirrhosis.

Pol S, Carnot F, Nalpas B, Lagneau JL, Fontaine H, Serpaggi J, Serfaty L, Bedossa P, Bréchot C. Pol S, et al. Among authors: bedossa p. Hum Pathol. 2004 Jan;35(1):107-12. doi: 10.1016/j.humpath.2003.08.012. Hum Pathol. 2004. PMID: 14745732

2

Approaches for treatment of liver fibrosis in chronic hepatitis C.

Bedossa P, Paradis V. Bedossa P, et al. Clin Liver Dis. 2003 Feb;7(1):195-210. doi: 10.1016/s1089-3261(02)00076-4. Clin Liver Dis. 2003. PMID: 12691467 Review.

3

Liver extracellular matrix in health and disease.

Bedossa P, Paradis V. Bedossa P, et al. J Pathol. 2003 Jul;200(4):504-15. doi: 10.1002/path.1397. J Pathol. 2003. PMID: 12845618 Review.

4

Respective roles of porto-septal fibrosis and centrilobular fibrosis in alcoholic liver disease.

Michalak S, Rousselet MC, Bedossa P, Pilette C, Chappard D, Oberti F, Gallois Y, Calès P. Michalak S, et al. Among authors: bedossa p. J Pathol. 2003 Sep;201(1):55-62. doi: 10.1002/path.1412. J Pathol. 2003. PMID: 12950017

5

Quantitative RT-PCR in cirrhotic nodules reveals gene expression changes associated with liver carcinogenesis.

Colombat M, Paradis V, Bièche I, Dargère D, Laurendeau I, Belghiti J, Vidaud M, Degott C, Bedossa P. Colombat M, et al. Among authors: bedossa p. J Pathol. 2003 Oct;201(2):260-7. doi: 10.1002/path.1451. J Pathol. 2003. PMID: 14517843

6

Molecular profiling of early stage liver fibrosis in patients with chronic hepatitis C virus infection.

Bièche I, Asselah T, Laurendeau I, Vidaud D, Degot C, Paradis V, Bedossa P, Valla DC, Marcellin P, Vidaud M. Bièche I, et al. Among authors: bedossa p. Virology. 2005 Feb 5;332(1):130-44. doi: 10.1016/j.virol.2004.11.009. Virology. 2005. PMID: 15661146 Free article.

7

Hepatic steatosis in HIV-HCV coinfected patients: analysis of risk factors.

Bani-Sadr F, Carrat F, Bedossa P, Piroth L, Cacoub P, Perronne C, Degott C, Pol S; ANRS HC02 - Ribavic Study team. Bani-Sadr F, et al. Among authors: bedossa p. AIDS. 2006 Feb 28;20(4):525-31. doi: 10.1097/01.aids.0000210606.63138.f5. AIDS. 2006. PMID: 16470116 Clinical Trial.

8

Efficacy of peginterferon alpha-2b in chronic hepatitis delta: relevance of quantitative RT-PCR for follow-up.

Castelnau C, Le Gal F, Ripault MP, Gordien E, Martinot-Peignoux M, Boyer N, Pham BN, Maylin S, Bedossa P, Dény P, Marcellin P, Gault E. Castelnau C, et al. Among authors: bedossa p. Hepatology. 2006 Sep;44(3):728-35. doi: 10.1002/hep.21325. Hepatology. 2006. PMID: 16941695

9

Glypican-3 expression in hepatocellular tumors: diagnostic value for preneoplastic lesions and hepatocellular carcinomas.

Wang XY, Degos F, Dubois S, Tessiore S, Allegretta M, Guttmann RD, Jothy S, Belghiti J, Bedossa P, Paradis V. Wang XY, et al. Among authors: bedossa p. Hum Pathol. 2006 Nov;37(11):1435-41. doi: 10.1016/j.humpath.2006.05.016. Epub 2006 Aug 10. Hum Pathol. 2006. PMID: 16949914

10

Direct and indirect evidence for the reversibility of cirrhosis.

Serpaggi J, Carnot F, Nalpas B, Canioni D, Guéchot J, Lebray P, Vallet-Pichard A, Fontaine H, Bedossa P, Pol S. Serpaggi J, et al. Among authors: bedossa p. Hum Pathol. 2006 Dec;37(12):1519-26. doi: 10.1016/j.humpath.2006.07.007. Epub 2006 Sep 25. Hum Pathol. 2006. PMID: 16997354

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

519 results

Search Page

Filters